190 related articles for article (PubMed ID: 16981580)
1. [COPE trial].
Umemoto S; Kamiya A; Matsuzaki M; Ogihara T
Nihon Rinsho; 2006 Aug; 64 Suppl 6():470-4. PubMed ID: 16981580
[No Abstract] [Full Text] [Related]
2. Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.
Matsuzaki M; Ogihara T; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Abe K; Suzuki N; Eto T; Higaki J; Ito S; Kamiya A; Kikuchi K; Suzuki H; Tei C; Ohashi Y; Saruta T;
J Hypertens; 2011 Aug; 29(8):1649-59. PubMed ID: 21610513
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.
Ogihara T; Matsuzaki M; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
Hypertens Res; 2012 Apr; 35(4):441-8. PubMed ID: 22278623
[TBL] [Abstract][Full Text] [Related]
4. Is there an optimal combination of antihypertensives for preventing cardiovascular events?
Teo KK
J Hypertens; 2011 Aug; 29(8):1483-5. PubMed ID: 21750437
[No Abstract] [Full Text] [Related]
5. Arterial hypertension: second-line treatment. Try other single-agent treatments.
Prescrire Int; 2008 Jun; 17(95):115-8. PubMed ID: 18630388
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial.
Rakugi H; Ogihara T; Umemoto S; Matsuzaki M; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
Hypertens Res; 2013 Nov; 36(11):947-58. PubMed ID: 23864054
[TBL] [Abstract][Full Text] [Related]
7. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
Rahn KH
Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
[TBL] [Abstract][Full Text] [Related]
8. [Large-scale trials in hypertension: clinical relevance and evaluation].
Tsukiyama H; Okada K
Nihon Rinsho; 2006 Aug; 64 Suppl 6():387-95. PubMed ID: 16981569
[No Abstract] [Full Text] [Related]
9. [CASE-J].
Fukui T
Nihon Rinsho; 2006 Aug; 64 Suppl 6():449-53. PubMed ID: 16981578
[No Abstract] [Full Text] [Related]
10. [LIFE].
Hiwada K
Nihon Rinsho; 2006 Aug; 64 Suppl 6():408-13. PubMed ID: 16981571
[No Abstract] [Full Text] [Related]
11. [Persistence and adherence: Comparison between the five classes diuretics, beta-blocker, calcium channel blockers, ACE-inhibitors and angiotensin receptor blockers as the first line in antihypertensive therapy].
Rossol-Haseroth K; Eckes L; Schroeder A
MMW Fortschr Med; 2011 Mar; 153 Suppl 1():21-5. PubMed ID: 21591327
[No Abstract] [Full Text] [Related]
12. [ALLHAT trial--antithesis to the overuse of vasodilating antihypertensive drugs].
Kuwajima I
Nihon Rinsho; 2004 Mar; 62 Suppl 3():648-53. PubMed ID: 15171450
[No Abstract] [Full Text] [Related]
13. [HOMED-BP].
Asayama K; Ohkubo T; Imai Y
Nihon Rinsho; 2006 Aug; 64 Suppl 6():459-64. PubMed ID: 16983777
[No Abstract] [Full Text] [Related]
14. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.
Ishimitsu T; Numabe A; Masuda T; Akabane T; Okamura A; Minami J; Matsuoka H
Hypertens Res; 2009 Nov; 32(11):962-8. PubMed ID: 19696778
[TBL] [Abstract][Full Text] [Related]
15. ASCOT blood pressure-lowering arm--study of effects of two BP-lowering regimens in hypertensive patients with cardiovascular risk factors.
Cardiovasc J S Afr; 2005; 16(2):124, 126-7. PubMed ID: 15915281
[No Abstract] [Full Text] [Related]
16. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
17. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
[TBL] [Abstract][Full Text] [Related]
18. [Management of hypertensive patients with cardiovascular damage].
Tomiyama H; Takata Y; Yamashina A
Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
[No Abstract] [Full Text] [Related]
19. [Hypertension 2007-2008].
Chatzikyrkou C; Menne J; Haller H
Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
[TBL] [Abstract][Full Text] [Related]
20. Hypertension in the elderly: treatment.
Schulman SP; Gerstenblith G
Cardiol Clin; 1986 May; 4(2):245-52. PubMed ID: 2871936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
